Effect of Intrapulpal Injections on the Post-endodontic Pain
Pulpitis - Irreversible
About this trial
This is an interventional treatment trial for Pulpitis - Irreversible
Eligibility Criteria
Inclusion Criteria: Symptomatic carious exposed mandibular first or second molars. Positive and prolonged response to thermal sensitivity tests and electric pulp tests. Vital coronal pulp on access cavity preparation. American Society of Anesthesiologists class I or II medical history. Ability to understand the use of pain scales. Exclusion Criteria: Active pain in more than 1 tooth. Teeth with fused roots. Radiographic evidence of an extra root. Large restorations with overhanging margins. Full crowns or deep periodontal pockets. Known allergy or contraindications to any content of the local anesthetic solution or NSAIDs History of known or suspected drug abuse. Taking any drugs which could affect the pain perception, e.g, opiods, antidepressants, anticonvulsants, muscle relaxants, anxiolytics, sedatives, nsaids. 23 Pregnant or breastfeeding patients. Patients with asthma, gastric ulcers, and bleeding disorders.
Sites / Locations
- Faculty of Dentistry, Jamia MIliia Islamia
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Supplementary Intrapulpal injection
Intraligamentary injection
Supplementary Intrapulpal injections were given using a 30-gauze needle with sufficient back pressure.
Intraligamentary injections were given using an intraligamentary syringe with back-pressure after a failed primary inferior alveolar nerve block.